Holdings (as at 2026-08-04)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Regeneron Pharmaceuticals, Inc. 2.73%
Boston Scientific Corporation 2.57%
Solventum Corporation 2.55%
Universal Health Services, Inc. (Class B) 2.52%
Zimmer Biomet Holdings, Inc. 2.49%
Guardant Health, Inc. 2.38%
Medline Inc. (Class A) 2.38%
Pfizer Inc. 2.36%
Globus Medical, Inc. (Class A) 2.31%
DaVita Inc. 2.29%
Natera, Inc. 2.27%
Tenet Healthcare Corporation 2.26%
Centene Corporation 2.23%
The Cigna Group 2.22%
Corcept Therapeutics Inc. 2.11%
Axsome Therapeutics, Inc. 1.94%
ResMed Inc. 1.91%
Medtronic Plc 1.84%
Arrowhead Pharmaceuticals, Inc. 1.83%
Encompass Health Corporation 1.82%
QIAGEN N.V. 1.81%
Incyte Corporation 1.78%
Halozyme Therapeutics, Inc. 1.78%
Zoetis Inc. 1.77%
Neurocrine Biosciences, Inc. 1.64%
Elevance Health Inc. 1.63%
United Therapeutics Corporation 1.59%
Eli Lilly and Company 1.55%
Bristol-Myers Squibb Company 1.53%
Ascendis Pharma A/S 1.53%
Becton, Dickinson and Company 1.51%
Viatris Inc. 1.50%
Labcorp Holdings Inc. 1.50%
Quest Diagnostics Incorporated 1.48%
Steris Plc 1.48%
GE HealthCare Technologies Inc. 1.47%
Medpace Holdings, Inc. 1.46%
Gilead Sciences, Inc. 1.44%
Doximity, Inc. (Class A) 1.42%
Exelixis, Inc. 1.38%
Revolution Medicines, Inc. 1.38%
Biogen Inc. 1.30%
Veeva Systems Inc. (Class A) 1.00%
IQVIA Holdings Inc. 0.99%
Abbott Laboratories 0.97%
Chemed Corporation 0.96%
Thermo Fisher Scientific Inc. 0.94%
Ionis Pharmaceuticals, Inc. 0.93%
BridgeBio Pharma, Inc. 0.92%
Henry Schein, Inc. 0.89%
Agilent Technologies, Inc. 0.87%
Align Technology, Inc. 0.86%
HCA Healthcare, Inc. 0.86%
Organon & Co. 0.84%
Vertex Pharmaceuticals Incorporated 0.81%
AbbVie Inc. 0.81%
Madrigal Pharmaceuticals, Inc. 0.79%
Tempus AI, Inc. (Class A) 0.68%
DexCom, Inc. 0.54%
Illumina, Inc. 0.48%
Bio-Rad Laboratories, Inc. (Class A) 0.47%
IDEXX Laboratories, Inc. 0.46%
The Ensign Group, Inc. 0.46%
Amgen Inc. 0.45%
Stryker Corporation 0.44%
BioMarin Pharmaceutical Inc. 0.44%
Envista Holdings Corporation 0.44%
Danaher Corporation 0.43%
The Cooper Companies, Inc. 0.43%
Johnson & Johnson 0.42%
Merck & Co., Inc. 0.42%
Revvity, Inc. 0.42%
West Pharmaceutical Services, Inc. 0.41%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.